SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-004906
Filing Date
2024-01-19
Accepted
2024-01-19 16:45:26
Documents
4
Period of Report
2024-01-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea191800-6k_altamira.htm 6-K 17505
2 AT THE MARKET OFFERING AGREEMENT, DATED AS OF JANUARY 19, 2024, BY AND BETWEEN A ea191800ex1-1_altamira.htm EX-1.1 221731
3 OPINION OF CONYERS DILL & PEARMAN LIMITED, BERMUDA COUNSEL TO ALTAMIRA THERAPEUT ea191800ex5-1_altamira.htm EX-5.1 35361
4 GRAPHIC ex5-1_001.jpg GRAPHIC 4273
  Complete submission text file 0001213900-24-004906.txt   282016
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 24546181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)